FeesSafety
Pluang+

Pendle and Centrifuge launch fixed-rate market for tokenized AAA CLOs on Base

Protocol Fundamentals
03 Nov 2026, 17:10 WIB
Crypto Briefing
View Source
Bullish
Pendle and Centrifuge launch fixed-rate market for tokenized AAA CLOs on Base

Pendle Finance and Centrifuge have partnered to create fixed-rate markets for tokenized real-world assets on the Base blockchain. Their first product, deJAAA, is linked to Janus Henderson’s AAA-rated collateralized loan obligation (CLO) strategy, allowing investors to split yield-bearing assets into fixed principal tokens and floating yield tokens. This collaboration leverages Centrifuge’s tokenization technology and Pendle’s yield-splitting mechanics, aiming to bring more structure and tradability to real-world credit in DeFi. The success of the deJAAA market, which matures in late November 2026, will be a key test for liquidity and adoption, with potential expansion to other tokenized products on Base.

The partnership between Pendle Finance and Centrifuge to create fixed-rate markets for tokenized real-world assets on Base is presented here with Pluang's market data as of Nov 03, 2026 21:24 WIB. On that day, out of 50 major cryptocurrencies priced on Pluang, 20 rose and 29 fell. Notable price movements include FTM at Rp11.382 with a 1-day change of -2.05%, ATOM at Rp26.017 with a 1-day change of -1.99% and strong buy activity at 96%, and ZIL at Rp33 with a 1-day change of -1.97%.

More News

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...

Market News
Bullish
58 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
3 hours ago
Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
3 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
3 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App